target glp 1 GLP-1/GIP Dual Weight Loss Innovative Drug - News Focus on Glucagon-like Peptide-1 Target:

As a result, the livers ability to produce the master antioxidant, glutathione, is reduced leading to oxidative damage, fatigue, and premature aging

In contrast, control mice with matching weight loss were not protected from atherosclerosis, suggesting that liraglutide has anti-atherogenic effects independent of weight loss

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

This happens partly because of weight loss but also because these medications reduce ectopic fat (unhealthy fat around organs) and decrease inflammation

Statistical significance was determined by Students t -test or using analysis of variance (ANOVA) with Tukey tests for post hoc comparisons at a 1% or 5% significance level of difference